Home Forums Main Forum Media & News Latest EASL July 2016 magazine publication.

Viewing 3 posts - 1 through 3 (of 3 total)
  • Author
    Posts
  • #19436
    Avatar photoTina-Hill-facebook
    • Guardian Angel
    • ★★★★★
    @tina-hill-facebook

    Hello

    I cant seem to be able to get the full txt version as yet however this is still worth the look. Turns out there is a published study saying there is a lack of evidence to support the suggestion that DAA’s may increase the chance of the re-occurrence of HCC.

    Is there is anyone who can get the full txt version and post it up?

    http://www.journal-of-hepatology.eu/


    SVR 24

    #19458
    Avatar photoAriel
    • Guardian Angel
    • ★★★★★
    @ariel

    Hello all,
    On the topic of HCC recurrence post DAA tx Social media voices are citing most interesting data. I’m seeing possible past influence going without a nod. Take for example Lucinda Porters concerns which will be well meant, her social media profile supports HCV patients.
    She cites re this issue however, from a cohort that underwent pegylated interferon plus riba tx.
    I’m always mindful of the effects of this old tx when I read on the topic of raised risk of malignancy of any type post DAAs.
    Take care and always ask your doc #flower

    https://www.hepmag.com/article/curing-hepatitis-c-risk-liver-cancer-remains-elevated

    http://www.ncbi.nlm.nih.gov/m/pubmed/26946190/

    #19539
    Avatar photosabrecat
    • Guardian Angel
    • ★★★★★
    @sabrecat

    “CONCLUSIONS: The risk of HCC after HCV cure, while considerably reduced, remains relatively high at 0.33% per year. Older age and/or presence of cirrhosis at the time of SVR are associated with a high enough risk to warrant surveillance. Diabetes is also a risk factor for post SVR HCC.”

    Always seems to come full circle treatment wise – get treated ASAP before your liver takes a beating (and you grow older).

    Jeff

Viewing 3 posts - 1 through 3 (of 3 total)
  • You must be logged in to reply to this topic.